January 9, 2019 11:45 AM EST
News Briefing

Roche names new Foun­da­tion Med chief; Ako­rn shares dip on FDA warn­ing let­ter; Zai Lab ad­vances piv­otal PARP study

Natalie Grover

Reporter

→ Six months af­ter Roche paid $2.4 bil­lion to buy com­plete con­trol of Foun­da­tion Med­i­cine the phar­ma gi­ant is fol­low­ing up by putting its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

Post-Hoc: Biose­cure is dead. Long live Biose­cure? 

A service from the Financial Times